New publications in health economics and genomics 10th January 2024

Four publications over the festive period:

  • Secondary (additional) findings from the 100,000 Genomes Project: disease manifestation, healthcare outcomes and costs of disclosure | link
  • The cost of proband and trio exome and genome analysis in rare disease: a micro-costing study | link
  • Cost Effectiveness of Genomic Population Health Screening in Adults: A Review of Modeling Studies and Future Directions | link
  • The Parent PrU: A measure to assess personal utility of pediatric genomic results | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

Leave a comment